Select Page

12:05 PM – 1:05 PM ET

The Therapeutic Transformation of Bladder Cancer: Understanding Immune, Targeted, and Antibody-Based Models for Patient Care

Matthew D. Galsky, MD
Sponsored by PeerView

Post-Test and CME Evaluation >>

1:05 PM – 1:45 PM ET

Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications

Emmanuel S. Antonarakis, MD
Sponsored by PeerView

Post-Test and CME Evaluation >>

Industry-Sponsored Product Theaters are not part of the CME accredited program.